Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
25.36
+0.47 (+1.89%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
34
35
Next >
Why Viking Therapeutics Stock Got Thrashed on Tuesday
↗
August 27, 2024
A monster rival is making aggressive moves in one particular segment.
Via
The Motley Fool
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
↗
August 27, 2024
The single-dose vials will also increase supply, the drug giant says.
Via
Investor's Business Daily
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
↗
August 26, 2024
The companies are chasing major innovations.
Via
The Motley Fool
Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
↗
August 26, 2024
The new drugs this company is developing could be worth a lot more than the present market value of its stock.
Via
The Motley Fool
(VKTX) - Analyzing Viking Therapeutics's Short Interest
↗
August 21, 2024
Via
Benzinga
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
↗
August 20, 2024
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Via
Talk Markets
Unpacking the Latest Options Trading Trends in Viking Therapeutics
↗
August 20, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today
↗
August 19, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
↗
August 05, 2024
Via
Benzinga
Could Viking Therapeutics Become the Next Novo Nordisk?
↗
August 17, 2024
Given this biotech's ascent, its odds of becoming a giant are better than most.
Via
The Motley Fool
3 Promising Biotech Stocks for the Long-Term: August 2024
↗
August 13, 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 12, 2024
Via
Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
↗
August 12, 2024
There isn't much to suggest these businesses are actually vulnerable.
Via
The Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
↗
August 08, 2024
News from a competitor gave investors an unwelcome dose of reality.
Via
The Motley Fool
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
↗
July 26, 2024
Via
Benzinga
3 Unstoppable Stocks to Buy in August
↗
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
↗
August 02, 2024
The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.
Via
The Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
↗
August 01, 2024
Anti-obesity therapeutics are all the rage and for good reason. Investors seeking to profit should consider these weight loss stocks.
Via
InvestorPlace
8 Health Care Stocks With Whale Alerts In Today's Session
↗
August 01, 2024
Via
Benzinga
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
↗
August 01, 2024
Pfizer's debt load could inhibit the company's ability to take on acquisitions in the near term.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
July 30, 2024
Via
Benzinga
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
↗
July 30, 2024
Both companies have a clear path to competing successfully in the market.
Via
The Motley Fool
3 Overlooked Stocks Poised for a Breakout Very Soon
↗
July 29, 2024
Discover three overlooked breakout stocks with solid growth prospects, perfect for enhancing your investment portfolio.
Via
InvestorPlace
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
↗
July 29, 2024
The Federal Reserve's fight against inflation may soon yield financial benefits.
Via
The Motley Fool
Topics
Economy
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
↗
July 29, 2024
One preliminary piece of evidence is sending its shares higher.
Via
The Motley Fool
Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
↗
July 29, 2024
Should you get in on this stock now?
Via
The Motley Fool
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
↗
July 28, 2024
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%
Via
Benzinga
Is Viking Therapeutics a Millionaire-Maker Stock?
↗
July 27, 2024
The stock rose 120% in one trading session earlier this year on positive clinical trial news.
Via
The Motley Fool
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
↗
July 26, 2024
Small caps continued to lead, while the Nasdaq broke below key levels.
Via
Investor's Business Daily
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
↗
July 25, 2024
Companies like Novo Nordisk and Eli Lilly might soon have a determined competitor in their hottest product category.
Via
The Motley Fool
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
